CDC published updated recommendation for meningococcal vaccination of at-risk children age 2-10 years in MMWR
On Oct. 17, 2007, the Food and Drug Administration (FDA) approved quadrivalent meningococcal conjugate vaccine (MCV4) (Menactra®, Sanofi…
On Oct. 17, 2007, the Food and Drug Administration (FDA) approved quadrivalent meningococcal conjugate vaccine (MCV4) (Menactra®, Sanofi…
On Sept. 28, 2007, the U.S. Food and Drug Administration (FDA) approved an Australian-made influenza vaccine called Afluria…
On Sept. 20, 2007, the U.S. Food and Drug Administration (FDA) approved use of FluMist nasal-spray influenza vaccine…
On Aug 10, 2007, the U.S. Centers for Disease Control and Prevention (CDC) notified MMWR readers of revised…
On Jul. 20, 2007, the U.S. Centers for Disease Control and Prevention (CDC) announced in MMWR that revised…
On Jul. 17, 2007, The U.S. Department of Health and Human Services (HHS) announced it was providing states,…
On Jun. 14, 2007, the U.D. of Health and Human Services (HHS) awarded $132.5 million to Sanofi Pasteur…
On Jun. 7, 2007, years before the COVID-19 pandemic swept across the globe, a group of about 100…
On May 8, 2007, the National Cancer Institute (NCI) reported that people infected with the hepatitis C virus…
On Apr. 17, 2007, Sanofi announced that the U.S. Food and Drug Administration (FDA) had licensed its H5N1…
On Mar. 28, 2007, the U.S. Food and Drug Administration (FDA) announced that GlaxoSmithKline (King of Prussia, Pennsylvania)…
On Feb. 1, 2007, the Centers for Disease Control and Prevention (CDC) released its long-awaited disease containment strategy…
On Jan. 9, 2007, the Executive Committee of the Council of State and Territorial Epidemiologists approved an interim…
In January 2007, scientists at the University of Iowa reported in the Journal of Virology that they had…
On Apr. 25, 2007, Jubilant Organosys, Ltd. announced it had acquired Spokane-based Hollister-Stier for $122.5 million. The plant…
In 2007, researchers at Livermore National Laboratory announced they had developed candidate signatures for pathogens that might be…
On Jun. 29, 2006, the Immunization Practices Advisory Committee (ACIP) recommends second dose of varicella vaccine for children.
On May 25, 2006, Zostavax, manufactured by Merck & Co. of Whitehouse Station, New Jersey, was approved by…
On May 18, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported on a multi-state mumps…
On Feb. 3, 2006, Rotavirus vaccine, live, oral, pentavalent (RotaTeq by Merck) was licensed for use in infants…
On Jan. 17, 2006, the Centers for Disease Control and Prevention (CDC) announced that it had stopped recommending…
On Jan. 6, 2006, the U.S. Centers for Disease Control and Prevention’s (CDC) advisory Committee on Immunization Practices…
In 2006, the U.S. Department of Agriculture (USDA) granted Dow AgroSciences the first regulatory approval for a plant-made…
In 2006, the Kansas State University Biosecurity Research Institute dedicated the Biosecurity Research Institute (BRI) that was designed…
On Dec. 23, 2005, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
On Dec. 19, 2005, in a 2-year legal battle over the U.S. military’s anthrax vaccination program, the Food…
On Oct. 30, 2005, the Bill & Melinda Gates Foundation announced three grants totaling $258.3 million for advanced…
On Oct. 7, 2005, a new Federal Medicare rule became effective that required all long-term care facilities to…
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
On Sept. 6, 2005, the vaccine that combined the measles, mumps, rubella, and varicella antigens (Proquad by Merck)…